GalNAc C5 Linker Synthesis with Vegetal Glucosamine Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for synthesizing peracetylgalactosamine-1-pentanoic acid (GalNAc C5 linker) rely on animal-derived materials, leading to impurities like peracetylgalactosamine-1-butanoic acid (M-14) that are difficult to remove, and there is a need for a more sustainable and cost-effective synthesis method using non-animal sourced starting materials.
Innovation Solution
The synthesis of peracetylgalactosamine-1-pentanoic acid is achieved using vegetal-sourced D-glucosamine or D-glucosamine hydrochloride as a starting material, employing a synthetic route that introduces glycosylation early in the process followed by C4 inversion, and includes re-crystallization to minimize impurities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If animal-derived galactosamine is used as starting material, then GalNAc C5 linker can be synthesized, but the product contains persistent impurities (M-14) that are difficult to remove
Solution Approach 1:
The patent extracts and eliminates the source of impurities by replacing animal-derived galactosamine with vegetal-derived glucosamine as the starting material. This substitution removes the origin of M-14 impurities from the synthesis pathway, achieving purification at the source rather than attempting to remove impurities after they are formed.
Solution Approach 2:
The patent changes the chemical starting material parameter from animal-derived galactosamine to vegetal-derived glucosamine. This fundamental parameter change in the raw material source eliminates the generation of persistent impurities while maintaining the ability to produce the desired GalNAc C5 linker product.
2Productivity
If traditional animal-sourced galactosamine is used, then synthesis can proceed, but the method is less sustainable and more expensive
Solution Approach 1:
The patent employs a readily available, inexpensive vegetal-derived glucosamine starting material that can be produced through sustainable fermentation processes. This replaces the more expensive and less sustainable animal-derived galactosamine, making the overall synthesis process more cost-effective and environmentally friendly.
Solution Approach 2:
The patent changes the source parameter of the starting material from animal-derived to vegetal-derived. This parameter change enables sustainable production through plant-based or fermentation-based glucosamine, eliminating dependence on animal sources while improving cost-effectiveness and sustainability metrics.
3Productivity
If 5-hexen-1-ol with 4-hexen-1-ol impurity is used, then glycosylation can occur, but M-14 impurity is formed in the product
Solution Approach 1:
The patent applies preliminary anti-action by preventing the formation of M-14 impurity at the source. By using high-purity 5-hexen-1-ol without 4-hexen-1-ol impurity and employing selective glycosylation conditions, the method prevents the unwanted side reaction that would generate M-14, rather than attempting to remove it afterward.
Solution Approach 2:
The patent extracts and removes the problematic 4-hexen-1-ol impurity from the 5-hexen-1-ol starting material before it can participate in side reactions. This pre-purification step eliminates the source of M-14 impurity formation, ensuring high product purity from the outset.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method produces GalNAc C5 linker that is nearly 100% pure and free of persistent impurities, meeting the detection limit requirements, while being more sustainable and economically viable.
Implementation Method 1
a synthetic route that introduces glycosylation of a lipophilic, masked carboxylate, followed by C4 inversion
Implementation Method 2
The methods disclosed herein allows for the cost-effective synthesis of GalNAc conjugated straight chain acids that are nearly 100% pure and free of persistent and difficult to remove impurities
Data Source
AI summary
The disclosure provides methods for synthesis of peracetylgalactosamine-1-pentanoic acid, also called peracetylated D-galactosamine C5 linker or GalNAc C5 linker, using a vegetal source as a starting material, such as vegetal-sourced D-glucosamine or D-glucosamine hydrochloride. Also provided are methods for purifying the peracetylgalactosamine-1-pentanoic acid, or GalNAc C5 linker, thus produced so that the end product comprises fewer impurities.